Literature DB >> 14709847

Risk factors for adrenal crisis in patients with adrenal insufficiency.

Kazue Omori1, Kaoru Nomura, Satoru Shimizu, Nariko Omori, Kazue Takano.   

Abstract

Patients with adrenal insufficiency have a life-threatening risk of adrenal crisis, thus preventing adrenal crisis is an important clinical issue. In order to clarify the risk factors for adrenal crisis, the medical records of 137 patients with established adrenal insufficiency were retrospectively investigated. The explanatory variables analyzed were gender, etiology of hypoadrenalism, class of adrenocortical hormone replaced, duration of steroid replacement, age at time of survey, age at time of diagnosis of hypoadrenalism, state of other hormone deficiencies (growth hormone and sex steroids), diabetes insipidus, and mental disorder. Diagnosis of adrenal crisis was based on physical and laboratory findings. Forty (29%) of the 137 patients had at least one episode of adrenal crisis. Based on the Akaike Information Criterion (AIC), steroid replacement therapy of more than 4 yrs' duration was the largest single contributor to the occurrence of an adrenal crisis, followed by mental disorder and sex steroid deficiency. In the subclass of patients with secondary adrenal insufficiency (N = 115), sex steroid deficiency was the greatest risk factor. Patients with untreated hypogonadism had a significantly higher relative risk of 3.70 (95% confidential interval: 1.71-7.98) compared to those without hypogonadism or with treated hypogonadism. Furthermore, among patients with hypogonadism aged younger than 50 yrs, those treated with sex hormone (5/51: 10%) suffered less frequently from adrenal crisis than those untreated (7/11: 64%, p = 0.0004). In conclusion, the present study has, for the first time, clarified the risk factors of adrenal crisis. Among them, sex hormone deficiency has an especially important implication because it can be treated by hormone replacement therapy with the hope of reducing the risk of adrenal crisis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14709847     DOI: 10.1507/endocrj.50.745

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  10 in total

Review 1.  Adrenal insufficiency in pregnancy: challenging issues in diagnosis and management.

Authors:  Kevin C J Yuen; Lindsay E Chong; Christian A Koch
Journal:  Endocrine       Date:  2013-02-02       Impact factor: 3.633

2.  Clinical Reasoning: An 87-year-old man with chronic obstructive pulmonary disease and acute encephalopathy.

Authors:  Kristyn Spera; Daniel Rubin; Tina Gupta; Tadeu Fantaneanu; Galen V Henderson
Journal:  Neurology       Date:  2016-09-27       Impact factor: 9.910

3.  Safer care for patients with adrenal insufficiency: weighing the evidence, balancing risks and acknowledging uncertainties.

Authors:  Michael Stacey; Robert M Gifford; David Woods
Journal:  Clin Med (Lond)       Date:  2021-09       Impact factor: 5.410

4.  Need and Viability of Newborn Screening Programme in India: Report from a Pilot Study.

Authors:  Arya Raveendran; Teena Joseph Chacko; Priya Prabhu; Raghava Varma; Leslie Edward Lewis; Pragna Rao; Prajna P Shetty; Yajna S Phaneendra Mallimoggala; Asha Hedge; Dinesh M Nayak; Sudeep Moorkoth; Sudheer Moorkoth
Journal:  Int J Neonatal Screen       Date:  2022-03-29

Review 5.  Adrenal crises in adolescents and young adults.

Authors:  R Louise Rushworth; Georgina L Chrisp; Suzannah Bownes; David J Torpy; Henrik Falhammar
Journal:  Endocrine       Date:  2022-05-18       Impact factor: 3.925

6.  Using the electronic medical record to improve education in patients at risk for adrenal insufficiency.

Authors:  Bahareh Schweiger; Philip Zeitler; Scott Eppley; Marguerite Swietlik; Jennifer Barker
Journal:  Int J Pediatr Endocrinol       Date:  2010-07-20

7.  Clinical characteristics of adrenal crisis in adult population with and without predisposing chronic adrenal insufficiency: a retrospective cohort study.

Authors:  Masahiro Iwasaku; Maki Shinzawa; Shiro Tanaka; Kimihiko Kimachi; Koji Kawakami
Journal:  BMC Endocr Disord       Date:  2017-09-11       Impact factor: 2.763

8.  Real-World Estimates of Adrenal Insufficiency-Related Adverse Events in Children With Congenital Adrenal Hyperplasia.

Authors:  Salma R Ali; Jillian Bryce; Houra Haghpanahan; James D Lewsey; Li En Tan; Navoda Atapattu; Niels H Birkebaek; Oliver Blankenstein; Uta Neumann; Antonio Balsamo; Rita Ortolano; Walter Bonfig; Hedi L Claahsen-van der Grinten; Martine Cools; Eduardo Correa Costa; Feyza Darendeliler; Sukran Poyrazoglu; Heba Elsedfy; Martijn J J Finken; Christa E Fluck; Evelien Gevers; Márta Korbonits; Guilherme Guaragna-Filho; Tulay Guran; Ayla Guven; Sabine E Hannema; Claire Higham; Ieuan A Hughes; Rieko Tadokoro-Cuccaro; Ajay Thankamony; Violeta Iotova; Nils P Krone; Ruth Krone; Corina Lichiardopol; Andrea Luczay; Berenice B Mendonca; Tania A S S Bachega; Mirela C Miranda; Tatjana Milenkovic; Klaus Mohnike; Anna Nordenstrom; Silvia Einaudi; Hetty van der Kamp; Ana Vieites; Liat de Vries; Richard J M Ross; S Faisal Ahmed
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

Review 9.  Therapeutic Patient Education for Adrenal Insufficiency under COVID-19 Pandemic Conditions.

Authors:  Tina Kienitz; Stefanie Hahner; Stephanie Burger-Stritt; Marcus Quinkler
Journal:  Exp Clin Endocrinol Diabetes       Date:  2020-08-06       Impact factor: 2.949

Review 10.  Clinical Unmet Needs in the Treatment of Adrenal Crisis: Importance of the Patient's Perspective.

Authors:  Kim M J A Claessen; Cornelie D Andela; Nienke R Biermasz; Alberto M Pereira
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-20       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.